The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...

Mumbai: The HSBC Hurun Global Indians List 2024 features 12 women, with Jayshree V. Ullal, Chairperson and CEO of Arista Networks, leading the list at 63. Ullal, whose company is valued at $128 ...

Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis. The approval marks a significant step for Lupin in the US market.

First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management Journavx is the first drug to be approved in this new class ...

Lakshmi Mittal and family lead with a fortune of Rs 1.84 lakh crore, closely followed by Gopichand Hinduja and family with Rs ...

The task ahead of Vertex now is to migrate patients already ... (liraglutide), used to treat type 2 diabetes, from India's Hikma Pharma. Victoza has been largely superseded by Novo Nordisk's ...

Satya Nadella, Chairman and CEO of Microsoft, has claimed the top spot in the inaugural HSBC Hurun Global Indians List 2024, ...